Methylphenidate. An update on extended-release formulations

Authors

• Monica Zolezzi

Abstract

Methylphenidate remains the mainstay of pharmacological management in attention deficit hyperactivity disorder (ADHD). Despite having been available for over half a century, methylphenidates original formulation has been modified with the main purpose of extending its duration of action. This article will present a brief review of how these new formulations vary and how these should be selected, considering the evidence available on their effectiveness and on the individual needs of the patient.

Article Type

Review

First Page

3

Last Page

7

Recommended Citation

Zolezzi, Monica (2007) "Methylphenidate. An update on extended-release formulations," Neurosciences: Vol. 12: Iss. 1, Article 2.
DOI: https://doi.org/10.17712/1658-3183.1459